Is GE Healthcare Technologies Inc. (GEHC) the Best Young Stock To Buy Now?
We recently compiled a list of 10 Best Young Stocks To Buy Now. In this article, we will look at where GE Healthcare ...
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET ...
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of ...
US FDA approves GE HealthCare's diagnostic drug for heart disease
The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery ...
GE HealthCare cut to sell by UBS over Chinese competition concerns
GE HealthCare (GEHC) was cut to sell by UBS on Thursday, with the bank asserting that risks such as increasing Chinese ...
Fintel on MSN3 天
UBS Downgrades GE HealthCare Technologies (GEHC)
Fintel reports that on September 26, 2024, UBS downgraded their outlook for GE HealthCare Technologies (NasdaqGS:GEHC) from ...
GE HealthCare的Flyrcado获FDA批准用于CAD检测
伊利诺伊州阿灵顿高地 - GE HealthCare (NASDAQ: GEHC) 获得美国食品和药物管理局（FDA）批准，可使用Flyrcado™（氟吡啶F 18）注射液，这是一种新型正电子发射断层扫描（PET）心肌灌注成像（MPI）剂。Flyrcado旨在检测冠状动脉疾病（CAD），与当前标准的单光子发射计算机断层扫描（SPECT）MPI相比，具有更高的诊断效能。 Flyrcado的批准基于其 ...
BTIG upgrades GE Healthcare Technologies Inc (GEHC) to a Buy
In a report released yesterday, Ryan Zimmerman from BTIG upgraded GE Healthcare Technologies Inc (GEHC – Research Report) to a Buy, with ...
Tech Moves: GE healthcare exec joins startup; Nautilus taps new CMO; WRF investor steps down
Selvan Senthivel is the new chief technology officer for the 6-year-old Seattle startup. Senthivel was most recently CTO for ...
GE HealthCare在ASTRO大会上展示肿瘤学创新成果
华盛顿特区 - GE HealthCare (NASDAQ:GEHC) 在2024年美国放射肿瘤学会(ASTRO)大会上介绍了其在放射肿瘤学领域的最新发展。这些新产品旨在简化临床医生和患者的放射治疗流程，有可能缩短从诊断到治疗的时间，这对改善患者预后至关重要。 公司展示的产品包括智能放射治疗(iRT)，该系统利用人工智能提高多供应商系统的互操作性和效率。iRT平台旨在通过将各种硬件和软件应用整合到 ...
SchaeffersResearch.com3 天
Analyst: Healthcare Stock Faces 2 Key Pressure Points
GE HealthCare Technologies (GEHC) is lower before the open, after a bear note from UBS pointed towards several risks ...
GE HealthCare Gets FDA Approval of Flyrcado to Diagnose Coronary Heart Disease
GE HealthCare has received approval for Flyrcado, its enhanced diagnosis tool for coronary heart disease, from the Food and Drug Administration. The company said on Friday that Flyrcado, or ...